News
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback